22
1
18
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2065 | Bioymifi | DR5 Activator | Apoptosis , TNF |
Bioymifi (DR5 Activator) is a novel and potent small-molecule activator of the TRAIL receptor DR5 in human cancer cells. | |||
T76815 | Lexatumumab | ETR2-ST01,DR5 mAB,HGS-ETR 2 | Apoptosis |
Lexatumumab (GHS-ETR 2) is a human excitatory monoclonal antibody targeting TRAIL receptor 2 that has anticancer activity and induces apoptosis in malignant mesothelioma. Lexatumumab can be used to study malignant pleura... | |||
T80984 | Tilogotamab | GEN-1029,HexaBody-DR5/DR5,Hx-DR5-01/05 | |
Tilogotamab (GEN-1029) is an enhanced hexameric mixture of two agonistic antibodies that bind to distinct epitopes on death receptor type 5 (DR5), specifically activating it. This compound is utilized in the research of ... | |||
T1167 | Cyproterone acetate | Androcur,Cyproterone 17-O-acetate | Androgen Receptor |
Cyproterone acetate (Cyproterone 17-O-acetate) binds the androgen receptor (AR), thereby preventing androgen-induced receptor activation in target tissues and inhibiting the growth of testosterone-sensitive tumor cells. ... | |||
T3201 | WDR5-0103 | WD-Repeat Protein 5-0103 | Histone Methyltransferase , JAK |
WDR5-0103 (WD-Repeat Protein 5-0103) is an effective and specific WD repeat-containing protein 5 (WDR5) antagonist (Kd: 450 nM). | |||
T5140 | WDR5-0103 hydrochloride[890190-22-4(free base)] | WD-Repeat Protein 5-0103 | JAK |
WDR5-0103 hydrochloride[890190-22-4(free base)] (WD-Repeat Protein 5-0103) is an effective and specific WD repeat-containing protein 5 (WDR5) antagonist (Kd: 450 nM). | |||
T67697 | WDR5-47 | Histone Methyltransferase | |
WDR5-47 is a potent small molecule to disturb the interaction of MLL1-WDR5 with IC50 value of 0.3μM. | |||
T67947 | WDR5-0102 | Histone Methyltransferase | |
WDR5-0102 is a compound that inhibits the WDR5-MLL1 interface (K dis = 7 μM, K d = 4 μM), selectively reducing MLL1 HMT activity without affecting the human H3K4 methyltransferase SETD7 or other HMTs, including G9a, EHMT... | |||
T77495 | WDR5-IN-6 | JAK | |
WDR5-IN-6 is a WDR5 inhibitor targeting the WBM locus.WDR5-IN-6 is highly synergistic with OICR-9429, a WDR5 inhibitor that targets the WIN locus.WDR5-IN-6 exhibits potent antitumor activity and inhibits cell proliferati... | |||
T63763 | WDR5-IN-5 | ||
WDR5-IN-5 is a selective, orally active inhibitor targeting the WD repeat domain 5 (WDR5) WIN site.WDR5-IN-5 exhibits high affinity for WDR5 (Ki<0.02 nM).WDR5-IN-5 exhibits anti-cancer cell proliferation and a good pharm... | |||
T73724 | WDR5-IN-4 TFA | ||
WDR5-IN-4 TFA is an inhibitor of the WIN site of chromatin-associated WD repeat-containing protein 5 ( WDR5 ), with a K d of 0.1 nM. WDR5-IN-4 TFA displaces WDR5 from chromatin and decreases the expression of associated ... | |||
T13334 | WDR5-IN-1 | Others | |
WDR5-IN-1 is a potent and selective inhibitor of WD repeat domain 5 (WDR5) (Kd <0.02 nM), and also inhibits MLL1 histone methyltransferase (HMT) activity (IC50: 2.2 nM). | |||
T74734 | Truncated ADR58 | ||
Truncated ADR58, derived by shortening full-length ADR58 from 71 bases to 31 bases, maintains comparable functional activity to its full-length counterpart. This compound acts as a potent and selective antagonist of huma... | |||
T13342 | WDR5-IN-4 | WIN site inhibitor 1 | Others |
WIN site inhibitor 1 is a WIN site of chromatin-associated WD repeat-containing protein 5 (WDR5) inhibitor (Kd: 0.1 nM), with anti-cancer activity. | |||
T76787 | Conatumumab | TRAIL-R2 mAb,AMG 655 | TNF |
Conatumumab (AMG 655) is a monoclonal agonist antibody targeting human death receptor 5 (DR5, TRAILR2) at Kd 1 nM for long DR5 and Kd 0.8 nM for short DR5. Conatumumab induces apoptosis in a variety of tumor types throug... | |||
T41068 | P53R3 | p53 | |
P53R3 is a potent reactivator of p53, effectively restoring sequence-specific DNA binding to several p53 hot spot mutants, namely p53 R175H, p53 R248W, and p53 R273H. This compound exhibits p53-dependent antiproliferativ... | |||
T26709 | Azadirone | ||
Azadirone is a limonoid tetranortriterpene. Azadirone can sensitize cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through ROS-ERK-CHOP-mediated up-regulation of DR4 and DR5 signaling, do... | |||
T76925 | Benufutamab | ||
Benufutamab (GEN1029), a death receptor 5 (DR5)-specific agonistic antibody, comprises a blend of two non-competing DR5-specific IgG1 antibodies with an E430G mutation in the Fc domain. This compound exhibits antitumor e... | |||
T76793 | Tigatuzumab | ||
Tigatuzumab (CS-1008), a humanized IgG1 monoclonal antibody, specifically targets death receptor 5 (DR5), inducing apoptosis in cancer cells and inhibiting tumor growth in vivo. It holds potential for cancer research app... | |||
T76802 | Drozitumab | ||
Drozitumab (PRO 95780) is an agonistic human monoclonal antibody targeting the death receptor DR5. It demonstrates significant antitumor efficacy against rhabdomyosarcoma [1] [2] [3]. | |||
T71230 | VMY-1-103 | ||
VMY-1-103 is a potent CDK inhibitor, is also a novel dansylated analog of purvalanol B, was shown to inhibit cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B... | |||
T35558 | KAAD-Cyclopamine | ||
Cyclopamine-KAAD is a potent inhibitor of hedgehog signaling with an IC50 value of 20 nM in a Shh-LIGHT2 assay. It blocks binding of BODIPY-cyclopamine to cells expressing Smoothened (Smo) in a dose-dependent manner. Cyc... |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T1678 | Nystatin | Stamycin,Fungicidin,Nystavescent | Apoptosis , Antibiotic , Antifungal |
Nystatin (Fungicidin) is a topical and oral antifungal agent with activity against many species of yeast and candida albicans, which is used largely to treat skin and oropharyngeal candidiasis. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01185 | DR5/TRAIL R2 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
DR5/TRAIL R2 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 15.7 kDa and the accession number is O14763-1. | |||
TMPY-05388 | DR5/TRAIL R2 Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
DR5/TRAIL R2 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 41 kDa and the accession number is AAB67103.1. | |||
TMPJ-00246 | TRAIL R2/DR5/TNFRSF10B Protein, Mouse, Recombinant (hFc) | Mouse | HEK293 Cells |
TRAIL R2/DR5/TNFRSF10B Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with C-Fc tag. The predicted molecular weight is 50-75 KDa and the accession number is Q9QZM4. | |||
TMPY-05477 | DR5/TRAIL R2 Protein, Human, Recombinant (His), Biotinylated | Human | HEK293 Cells |
DR5/TRAIL R2 Protein, Human, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 15.8 kDa and the accession number is O14763-1. | |||
TMPK-00276 | TRAIL R2/DR5/TNFRSF10B Protein, Human, Recombinant (His & Avi) | Human | HEK293 Cells |
DR5, also called TRAIL R2, TRICK 2, TNFRSF10B, and MK is a type 1 TNF R superfamily, membrane protein which is a receptor for TRAIL (APO2 ligand). DR5 is a receptor for the cytotoxic ligand TNFSF10/TRAIL. The resulting d... | |||
TMPY-01452 | DR5/TRAIL R2 Protein, Mouse, Recombinant (His & hFc) | Mouse | HEK293 Cells |
DR5/TRAIL R2 Protein, Mouse, Recombinant (His & hFc) is expressed in HEK293 mammalian cells with His and hFc tag. The predicted molecular weight is 41.8 kDa and the accession number is Q9QZM4. | |||
TMPK-00277 | TRAIL R2/DR5/TNFRSF10B Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
DR5, also called TRAIL R2, TRICK 2, TNFRSF10B, and MK is a type 1 TNF R superfamily, membrane protein which is a receptor for TRAIL (APO2 ligand). DR5 is a receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter mol... | |||
TMPY-01437 | DR5/TRAIL R2 Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells |
DR5/TRAIL R2 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 15 kDa and the accession number is Q9QZM4. | |||
TMPY-06835 | DR5/TRAIL R2 Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 Cells |
DR5/TRAIL R2 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 17.54 kDa and the accession number is NP_003833.4. | |||
TMPJ-00245 | TRAIL R2/DR5/TNFRSF10B Protein, Mouse, Recombinant (Avi & His), Biotinylated | Mouse | HEK293 Cells |
TRAIL R2/DR5/TNFRSF10B Protein, Mouse, Recombinant (Avi & His), Biotinylated is expressed in HEK293 mammalian cells with C-Avi-6xHis tag. The predicted molecular weight is 20-40 KDa and the accession number is Q9QZM4. | |||
TMPJ-00276 | TRAIL R2/DR5/TNFRSF10B Protein, Human, Recombinant (hFc & His) | Human | HEK293 Cells |
TRAIL R2/DR5/TNFRSF10B Protein, Human, Recombinant (hFc & His) is expressed in HEK293 mammalian cells with C-Fc-6xHis tag. The predicted molecular weight is 49 KDa and the accession number is O14763. | |||
TMPJ-00430 | TRAIL R2/DR5/TNFRSF10B Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 Cells |
TRAIL R2/DR5/TNFRSF10B Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 22-30 KDa and the accession number is A0A2K5TXK0. | |||
TMPJ-00275 | TRAIL R2/DR5/TNFRSF10B Protein, Human, Recombinant (Avi & His), Biotinylated | Human | HEK293 Cells |
TRAIL R2/DR5/TNFRSF10B Protein, Human, Recombinant (Avi & His), Biotinylated is expressed in HEK293 mammalian cells with C-Avi-6xHis tag. The predicted molecular weight is 18-25 KDa and the accession number is O14763. | |||
TMPH-02311 | WDR5 Protein, Human, Recombinant (His & SUMO) | Human | E. coli |
WDR5 Protein, Human, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 52.5 kDa and the accession number is P61964. | |||
TMPK-00171 | TRAIL Trimer Protein, Human, Recombinant (His & Flag) | Human | HEK293 Cells |
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily that can initiate the apoptosis pathway by binding to its associated death receptors DR4 and DR5. The activation of... | |||
TMPK-00708 | TRAIL R1/DR4/TNFRSF10A Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces apoptosis selectively via its interaction with the death receptors TRAILR1/DR4 and TRAILR2/DR5 in a wide range of cancers, while sparing norma... | |||
TMPK-00248 | TRAIL R4/TNFRSF10D Protein, Human, Recombinant (His & Avi) | Human | HEK293 Cells |
TNF-related apoptosis inducing ligand (TRAIL) is a potential antitumor protein known for its ability to selectively eliminate various types of tumor cells without exerting toxic effects in normal cells and tissues. TRAIL... | |||
TMPK-00249 | TRAIL R4/TNFRSF10D Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 Cells |
TNF-related apoptosis inducing ligand (TRAIL) is a potential antitumor protein known for its ability to selectively eliminate various types of tumor cells without exerting toxic effects in normal cells and tissues. TRAIL... |